Loading...
XSTO
PTRK
Market cap18mUSD
Apr 09, Last price  
11.45SEK
1D
15.19%
1Q
36.96%
IPO
-75.90%
Name

Physitrack PLC

Chart & Performance

D1W1MN
P/E
—
P/S
1.04
EPS
—
Div Yield, %
—
Shrs. gr., 5y
7.68%
Rev. gr., 5y
68.21%
Revenues
16m
+6.61%
23,68844,089237,564447,410857,0001,201,3865,827,6087,814,05612,510,37115,176,58216,180,498
Net income
-6m
L
-154,005-429,421-359,6240-206,716-205,914688,409-815,03592,3193,204,826-6,454,592
CFO
3m
+18.08%
0000705,601500,8942,032,506659,8101,451,6022,648,1343,126,841

Profile

Physitrack PLC, together with its subsidiaries, operates as a digital healthcare provider worldwide. It offers SaaS platform, a cloud-based software platform used by single practitioners and large healthcare organizations, which enables the digitalization of the patient journey, from initial contact to patient interactions and outcomes tracking. The company also delivers virtual care in three distinct but related patient and insurance plan member need areas, such as prevention and wellness care, acute and chronic care, and surgical care. It offers its virtual care solutions to healthcare companies, including private and public hospitals, clinics, and other business owners. The company was formerly known as Physitrack Limited and changed its name to Physitrack PLC in May 2021. Physitrack PLC was incorporated in 2012 and is based in London, the United Kingdom.
URL
https://www.physitrackgroup.com/
IPO date
Jun 18, 2021
Employees
85
Domiciled in
GB
Incorporated in
GB

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑112019‑112018‑112017‑112016‑112015‑11
Income
Revenues
16,180
6.61%
15,177
21.31%
12,510
60.10%
Cost of revenue
11,311
12,546
Unusual Expense (Income)
NOPBT
16,180
3,866
(35)
NOPBT Margin
100.00%
25.47%
Operating Taxes
(537)
(114)
(41)
Tax Rate
NOPAT
16,718
3,980
6
Net income
(6,455)
-301.40%
3,205
3,371.47%
92
-111.33%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
4,808
3,578
832
Deferred revenue
62
Other long-term liabilities
151
3,740
9,701
Net debt
4,085
2,964
175
Cash flow
Cash from operating activities
3,127
2,648
1,452
CAPEX
(41)
(25)
(4,496)
Cash from investing activities
(3,490)
(5,036)
(14,785)
Cash from financing activities
538
2,342
796
FCF
17,362
3,296
1,121
Balance
Cash
723
536
578
Long term investments
79
79
Excess cash
31
Stockholders' equity
(5,242)
1,671
(1,534)
Invested Capital
29,429
32,891
34,276
ROIC
53.65%
11.85%
0.02%
ROCE
64.31%
11.75%
EV
Common stock shares outstanding
16,261
16,261
16,261
Price
8.70
-46.30%
16.20
-32.36%
23.95
-58.85%
Market cap
141,469
-46.30%
263,424
-32.36%
389,445
-51.12%
EV
145,553
266,388
390,652
EBITDA
20,599
7,486
2,399
EV/EBITDA
7.07
35.58
162.86
Interest
487
375
87
Interest/NOPBT
3.01%
9.70%